Chemoinformaics analysis of 3-Phenylpropyl formate
| Molecular Weight | 164.204 | nRot | 5 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 7 |
| Exact Molecular Weight | 164.084 | nRing | 1 |
| Solubility: LogS | -2.289 | nHRing | 0 |
| Solubility: LogP | 2.479 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 26.3055 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.49 |
| Synth | 1.85 |
| Natural Product Likeliness | 0.292 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.013 |
| CACO-2 | -4.344 |
| MDCK | 0.0000413 |
| BBB | 0.995 |
| PPB | 0.44655 |
| VDSS | 4.107 |
| FU | 0.364442 |
| CYP1A2-inh | 0.987 |
| CYP1A2-sub | 0.415 |
| CYP2c19-inh | 0.922 |
| CYP2c19-sub | 0.112 |
| CYP2c9-inh | 0.416 |
| CYP2c9-sub | 0.118 |
| CYP2d6-inh | 0.359 |
| CYP2d6-sub | 0.221 |
| CYP3a4-inh | 0.069 |
| CYP3a4-sub | 0.306 |
| CL | 7.081 |
| T12 | 0.826 |
| hERG | 0.031 |
| Ames | 0.029 |
| ROA | 0.012 |
| SkinSen | 0.824 |
| Carcinogencity | 0.63 |
| EI | 0.965 |
| Respiratory | 0.064 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.907844 |